Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 4

The use of calcium and vitamin D in the management of osteoporosis

Authors Sunyecz J

Published 8 August 2008 Volume 2008:4(4) Pages 827—836

DOI https://doi.org/10.2147/TCRM.S3552

Review by Single-blind

Peer reviewer comments 2

John A Sunyecz

MenopauseRx, Inc., Uniontown, PA, USA

Abstract: Osteoporosis poses a significant public health issue, causing significant morbidity and mortality. Calcium and vitamin D utilization in the optimization of bone health is often overlooked by patients and health care providers. In addition, the optimal standard of care for osteoporosis should encompass adequate calcium and vitamin D intake. Dietary intake or supplementation with calcium and vitamin D will be reviewed, including recent recommendations for increased vitamin D intake. Compliance to calcium and vitamin D therapy is paramount for effective prevention of osteoporotic fractures. A recently released algorithm (FRAX) estimating absolute fracture risk allows the health care provider to decide when pharmacologic therapy is warranted in addition to calcium and vitamin D. When pharmacologic therapy is advised, continued use of calcium and vitamin D is recommended for optimal fracture risk reduction. A ‘bricks and mortar’ analogy is often helpful when counseling patients and this analogy will be explained. This manuscript reviews relevant data related to calcium and vitamin D use for patients at risk for fracture due to bone loss.

Keywords: osteoporosis, calcium, vitamin D, osteopenia, hip fracture, bone

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

The Danish National Patient Registry: a review of content, data quality, and research potential

Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT

Clinical Epidemiology 2015, 7:449-490

Published Date: 17 November 2015

Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer

Wu SK, Chiang CF, Hsu YH, Lin TH, Liou HC, Fu WM, Lin WL

International Journal of Nanomedicine 2014, 9:4485-4494

Published Date: 19 September 2014

Risky substance exposure during pregnancy: a pilot study from Lebanese mothers

Rachidi S, Awada S, Al-Hajje A, Bawab W, Zein S, Saleh N, Salameh P

Drug, Healthcare and Patient Safety 2013, 5:123-131

Published Date: 15 May 2013

Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption

Bei YY, Chen XY, Liu Y, Xu JY, Wang WJ, Gu ZL, Xing KL, Zhu AJ, Chen WL, Shi LS, Wang Q, Zhang XN, Zhang Q

International Journal of Nanomedicine 2012, 7:1819-1827

Published Date: 3 April 2012

Utility of ranolazine in chronic stable angina patients

Pawan D Patel, Rohit R Arora

Vascular Health and Risk Management 2008, 4:819-824

Published Date: 8 August 2008

Systematic review of implementation strategies for risk tables in the prevention of cardiovascular diseases

Ben van Steenkiste, Richard Grol, Trudy van der Weijden

Vascular Health and Risk Management 2008, 4:535-545

Published Date: 6 June 2008

Epidemiology and treatment of post-stroke depression

Stefano Paolucci

Neuropsychiatric Disease and Treatment 2008, 4:145-154

Published Date: 8 February 2008